Unlike larger proteins that undergo hepatic metabolism or receptor-mediated endocytosis for degradation, KLOW's primary clearance route is direct renal excretion
This peptide variant is derived from angiotensin IV
NCCN will update its guidelines continuously as data evolve and plans to include toxicities of new CAR-T cell therapies later this year
Melanotan 2 (MT2) is a synthetic cyclic heptapeptide analogue of -melanocyte-stimulating hormone and a non-selective agonist at melanocortin receptors MC1R, MC3R, MC4R, and MC5R
Check out the paper and hats off for the tremendous work to Andrs Felipe Prez Palacios, Jorge Parra, Daniel Santiago Crdoba Velasco, Diana Carolina Zona Rubio, IZABEL ALMEIDA ALVES & Diana Marcela Aragon Novoa To view or add a comment, sign in #VNDA is a cash-rich small-cap biopharma trying to outrun a 2027 patent cliff, now with a newly approved motion-sickness drug and multiple near-term FDA catalysts